Literature DB >> 32694755

MicroRNA-302a promotes neointimal formation following carotid artery injury in mice by targeting PHLPP2 thus increasing Akt signaling.

Ying-Ying Liu1, Xiu Liu1, Jia-Guo Zhou1, Si-Jia Liang2.   

Abstract

The excessive proliferation and migration of smooth muscle cells (SMCs) play an important role in restenosis following percutaneous coronary interventions. MicroRNAs are able to target various genes and involved in the regulation of diverse cellular processes including cell growth and proliferation. In this study we investigated whether and how MicroRNAs regulated vascular SMC proliferation and vascular remodeling following carotid artery injury in mice. We showed that carotid artery injury-induced neointimal formation was remarkably ameliorated in microRNA (miR)-302 heterozygous mice and SMC-specific miR-302 knockout mice. In contrast, delivery of miR-302a adenovirus to the injured carotid artery enhanced neointimal formation. Upregulation of miR-302a enhanced the proliferation and migration of mouse aorta SMC (MASMC) in vitro by promoting cell cycle transition, whereas miR-302a inhibition caused the opposite results. Moreover, miR-302a promoted Akt activation by corporately decreasing Akt expression and increasing Akt phosphorylation in MASMCs. Application of the Akt inhibitor GSK690693 (5 μmol/L) counteracted the functions of miR-302a in promoting MASMC proliferation and migration. We further revealed that miR-302a directly targeted at the 3' untranslated region of PH domain and leucine rich repeat protein phosphatase 2 (PHLPP2) and negatively regulated PHLPP2 expression. Restoration of PHLPP2 abrogated the effects of miR-302a on Akt activation and MASMC motility. Furthermore, knockdown of PHLPP2 largely abolished the inhibition of neointimal formation that was observed in miR-302 heterozygous mice. Our data demonstrate that miR-302a exacerbates SMC proliferation and restenosis through increasing Akt signaling by targeting PHLPP2.

Entities:  

Keywords:  Akt; PHLPP2; microRNA-302a; neointimal formation; proliferation; vascular smooth muscle cell

Mesh:

Substances:

Year:  2020        PMID: 32694755      PMCID: PMC8115114          DOI: 10.1038/s41401-020-0440-4

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  4 in total

1.  MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway.

Authors:  D-W Wang; Y-Q Wang; H-S Shu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-03       Impact factor: 3.507

2.  miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation.

Authors:  Tianji Chen; Qiyuan Zhou; Haiyang Tang; Melike Bozkanat; Jason X-J Yuan; J Usha Raj; Guofei Zhou
Journal:  J Am Heart Assoc       Date:  2016-12-05       Impact factor: 5.501

3.  Inhibition of miR-302 Suppresses Hypoxia-Reoxygenation-Induced H9c2 Cardiomyocyte Death by Regulating Mcl-1 Expression.

Authors:  Yao-Ching Fang; Chi-Hsiao Yeh
Journal:  Oxid Med Cell Longev       Date:  2017-04-11       Impact factor: 6.543

4.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Endometrial Cancer Cell Proliferation and Migration through Delivery of Exogenous miR-302a.

Authors:  Xin Li; Li Li Liu; Ju Lei Yao; Kai Wang; Hao Ai
Journal:  Stem Cells Int       Date:  2019-03-14       Impact factor: 5.443

  4 in total
  1 in total

1.  Inhibition of Long Noncoding RNA SNHG15 Ameliorates Hypoxia/Ischemia-Induced Neuronal Damage by Regulating miR-302a-3p/STAT1/NF-κB Axis.

Authors:  Chunting Hu; Chen Li; Qiaoya Ma; Ruili Wang; Ya He; Hui Wang; Guogang Luo
Journal:  Yonsei Med J       Date:  2021-04       Impact factor: 3.052

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.